Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04141917 · ClinicalTrials.gov registry record · Phase 4
Test-and-treat for Influenza in Homeless Shelters
A Phase 4 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1,618
- Enrollment target
NCT04141917 is a Phase 4 study that was terminated before completion, run by University of Washington. The registered enrollment target is 1,618 participants.
The verdict
NCT04141917, a Phase 4 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1,618 participants
- Enrollment target
Study Summary
This study is a stepped-wedge cluster-randomized trial of on-site rapid testing and treatment for influenza in homeless shelters within the Seattle area to determine whether this strategy reduced the incidence of influenza in the shelter environment.
Interventions
- COMBINATION_PRODUCT Point-of-care molecular testing and treatment of influenza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,618 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2021-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04141917
The ClinicalTrials.gov registry entry for NCT04141917 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1,618 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Point-of-care molecular testing and treatment of influenza is the first listed.
NCT04141917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04141917 about?
NCT04141917 is a clinical study titled "Test-and-treat for Influenza in Homeless Shelters". This study is a stepped-wedge cluster-randomized trial of on-site rapid testing and treatment for influenza in homeless shelters within the Seattle area to determine whether this strategy reduced the incidence of influenza in the shelter environment.
What is the current status of trial NCT04141917?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1,618 participants. The study started on 2019-11-15. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT04141917?
The interventions under investigation include: Point-of-care molecular testing and treatment of influenza (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04141917?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.